Kent MacLean

CEO & Director at Allumiqs

Kent MacLean is the CEO & Director of Allumiqs, PhenoSwitch Bioscience, and Proteoform Scientific, companies specializing in providing multiomics, mass spectrometry services, and data-driven solutions to the biopharma and life sciences industries. Additionally, Kent is the Founder & Executive Director of Arcos Technologies Inc., specializing in Microsoft Business Solutions, and the Managing Director of NextWave Corporation, an investment and industry advisory firm. Prior to these roles, Kent held various financial and project management positions at companies such as Slemon Park Corporation and Lapointe Sweeney Carter.

Links


Org chart

Sign up to view 2 direct reports

Get started